Automatic Cell Imaging System Market Analysis
Automatic Cell Imaging System Market — Global Industry Insights, Trends, Size, Share, Outlook, and Opportunity Analysis, 2018-2026
Live cell imaging, or cell imaging is the examination of living cells using time-lapse microscopy (time-lapse photography applied to microscopy). Cell Imaging is used by scientists to get a better understanding of the biological functions of the body in the course of the study of cellular dynamics. The process was established in first half of the 20th century. The first time-lapse microcinematographic films showed the development and fertilization of a sea urchin egg. Various methods of microscopy have since been developed, thereby allowing researchers to experiment on living cells with greater detail and with less effort. A new kind of imaging, which uses quantum dots, has been pioneered as they are found to be more stable.
Cell imaging has become an important tool in medical research. Automatic microscopy and image analysis are used to study a variety of different things such as the influence of chemical compounds on cell development. Researchers in this field primarily want to see which compounds capture the cell cycle or the time they take to incubate and at what concentration. Cell cycle is a rigid sequence of phases that a cell undergoes while it is on its dividing phase. If anything goes wrong at some stage during the transition from one phase to other, the cell generally enters cell death that is programmed. Studying these procedures needs intricate image analysis workflows that can be mind-numbing to ascertain. This process is sped up by the use of modular software. Automated cell imaging also find its usage in the drug discovery processes for various diseases, for instance, cancer drugs.
Automatic Cell Imaging System Market – Dynamics
As the occurrence of cancer is rising at an alarming rate, so is the need for automatic cell imaging system. Automatic cell imaging system offers grass root level analysis of the division of cancer cells and hence researchers are using this technique to find a cure to the fatal disease. This is likely to fuel the growth of the overall automatic cell imaging system market.
Rising prevalence of cancer is expected to propel the automatic cell imaging system market over the forecast period. According to the World Cancer Research Fund International (WCRFI), in 2012, around 14.1 million cancer cases were estimated worldwide, in which, around 7.4 men and 6.6 million female were diagnosed. As per WCRFI, it is predicted that by 2035, world-wide around 24 million cancer cases will increase. The most common cancers were breast cancer, colon and rectum cancer, kidney and renal pelvis cancer, prostate cancer, non-Hodgkin lymphoma, leukemia, thyroid cancer, lung and bronchus cancer, melanoma of the skin, bladder cancer, pancreatic cancer, and endometrial cancer. The quantity of new cases of cancer was 454.8 per 100,000 women and men per year (statistic based on 2008-2012 cases). Additionally, the number of deaths due to cancer was 171.2 per 100,000 women and men per year (statistic based on 2008-2012 cases).
Rising product approvals and product launch by the market players is expected to propel the market growth. For instance, in February 2018, Molecular Devices, LLC, launched ImageXpress Pico Automated Cell Imaging System which automates the manual procedures such as acquisition steps and post processing of images and offers user efficient tool in research work
Automatic Cell Imaging System Market – Regional Insights
North America held the maximum market share in automatic cell imaging system market globally. Rising incidences of cancer cases in the region is expected to bolster the market growth. According to a National Cancer Institute, 2016, an estimated 16.8 million new cases of cancer were diagnosed in the U.S., with around 595,690 deaths from the disease. The number of people with cancer is expected to rise to 19 million by 2024. Moreover, according to a report published in American Cancer Society’s Cancer Journal for Clinicians, around 1,735,350 new cancer cases are estimated to be diagnosed in 2018 in the U.S., including around 87,290 cases of melanoma.
Favorable and constructive policies and regulations, as well as availability of sophisticated healthcare facilities along with rising approvals about the usage of automatic cell imaging system from the governing bodies, are likely to fuel the growth of the automatic cell imaging system market in this region.
The automated microscopy process generates hundreds and thousands of images in a matter of few days; hence, potent image analysis software is required to differentiate between the various appearances of the cell. Manufacturers of automated microscopes generally offer image analysis software for the analyzing of the images that are produced by their hardware. The complexity with this software is to discover the right approach for a definite assay. The analysis desires robustness in order to cope with various situations and they should be fast enough to compute the results for the huge amount of images generated in a short time.
Automatic Cell Imaging System Market Taxonomy:
On the basis of product, automatic cell imaging system market segmented into:
On the basis of end user, automatic cell imaging system market segmented into:
On the basis of region, automatic cell imaging system market segmented into:
Key players in the automatic cell imaging system market:
Some of the key players operating in the automatic cell imaging system market includes GE Healthcare Life Sciences, West Medica, Norma Diagnostika GmbH, Bioview, Caliber I.D., Molecular Devices, BioTek Instruments, and PerkinElmer., Inc.